Amprion performs all testing services in its CAP-accredited and CLIA-certified laboratory. In addition, Amprion has licenses/permits from the states shown below.
California Department of Public Health
* Best view using Google Chrome, as some browsers may not display the certificate properly.
A pioneer in the science of detecting misfolded proteins, Amprion advances the diagnosis of brain disorders. Our SAAmplify™-ɑSYN Test aids physicians in diagnosing Parkinson’s, Lewy body dementia, and Alzheimer’s with Lewy body variant. We plan to launch more biomarker tests in the future.
Our flagship α-synuclein SAA, SYNTap®, is getting a makeover.
Effective September 9, 2024, SYNTap will be
And stay tuned for the SAAmplify family of panels, coming soon!
